Safety Assessment of Dose-Escalated 225Ac-PSMA-617 Radioligand Therapy in Patients With Advanced Metastatic Castration-Resistant Prostate Cancer Following Standard Treatment Failure. Вопр. онкол. 2025, 71 (5), OF-2520. https://doi.org/10.37469/0507-3758-2025-71-5-OF-2520.